I now have comprehensive, authoritative content from three major textbooks and the signaling diagram. Here is the full answer:
Mechanism of Action of Insulin
(Sources: Costanzo Physiology 7e, Tietz Textbook of Laboratory Medicine 7e, Goodman & Gilman's Pharmacological Basis of Therapeutics)
1. The Insulin Receptor
The insulin receptor is a heterotetrameric transmembrane glycoprotein consisting of:
- Two α-subunits (MW ~135,000 Da each) - located entirely extracellularly; contain the insulin-binding site
- Two β-subunits (MW ~95,000 Da each) - span the plasma membrane and extend intracellularly; contain intrinsic tyrosine kinase activity
The two α-subunits are linked to each other by disulfide bonds, and each α-subunit is connected to a β-subunit by a disulfide bond. - Costanzo Physiology 7e, p. 447
2. Step-by-Step Signaling Cascade
Step 1 - Ligand Binding & Receptor Activation
Insulin binds to the α-subunits of the receptor, inducing a conformational change that activates the tyrosine kinase domains of the β-subunits.
Step 2 - Autophosphorylation
The β-subunits phosphorylate themselves (autophosphorylation) on multiple tyrosine residues in the presence of ATP. This amplifies kinase activity further.
Step 3 - Phosphorylation of Intracellular Substrates
The activated receptor tyrosine kinase phosphorylates several key docking proteins:
- IRS proteins (IRS-1, IRS-2, IRS-3, IRS-4) - Insulin Receptor Substrate family; the most important downstream substrates
- Shc (Src homology 2 domain-containing protein)
- Grb2 (Growth factor receptor-bound protein 2)
The phosphorylated tyrosines on these proteins act as docking sites for intracellular signal transducers that contain SH2 (Src Homology 2) domains - ~100 amino acid sequences that specifically recognize phosphotyrosine. - Tietz 7e, p. 1721
3. Two Main Downstream Signaling Arms
FIGURE: Mechanism of insulin action (Tietz Textbook of Laboratory Medicine 7e)
A. Metabolic Arm - PI3K/Akt Pathway
This is the primary pathway for insulin's metabolic effects:
- Phosphorylated IRS proteins recruit and activate PI3K (Phosphatidylinositol 3-kinase)
- PI3K generates PIP3 (phosphatidylinositol 3,4,5-trisphosphate) at the membrane
- PIP3 recruits and activates PDK1 (3-phosphoinositide-dependent protein kinase-1)
- PDK1 phosphorylates and activates Akt (also known as PKB)
- Akt then mediates the key metabolic effects:
| Effect | Mechanism |
|---|
| GLUT4 translocation (muscle & adipose) | Akt promotes translocation of GLUT4 vesicles to plasma membrane → glucose uptake |
| Glycogen synthesis (liver) | Akt phosphorylates and inactivates GSK-3β → relieves inhibition of glycogen synthase |
| Suppression of gluconeogenesis (liver) | Akt inhibits FOXO transcription factors → reduces expression of gluconeogenic enzymes |
| Lipogenesis (liver) | Akt activates lipogenic pathways |
| Protein synthesis | Akt activates mTOR → ribosomal S6 kinase (S6K) → increased translation |
B. Mitogenic Arm - Ras/MAPK Pathway
This pathway mediates insulin's growth-promoting effects:
- Shc and Grb2 (bound to phosphorylated IRS or directly to the receptor) activate Ras
- Ras activates Raf → MEK → ERK (MAP kinase cascade)
- ERK activates S6K and nuclear transcription factors
- End effects: cell growth, differentiation, and gene transcription
C. Caveolar Pathway (Alternative)
A separate pool of insulin receptors in caveolae (lipid raft microdomains) phosphorylates caveolin (CAV), APS, and Cbl. This pathway also drives GLUT4 translocation via the CrkII-C3G-TC10 signaling axis. - Goodman & Gilman's, Figure 51-4
4. Receptor Internalization and Down-regulation
After insulin-receptor binding, the complex is internalized by receptor-mediated endocytosis. The receptor is then either:
- Degraded by intracellular proteases
- Stored intracellularly
- Recycled back to the cell membrane
Insulin down-regulates its own receptor by decreasing receptor synthesis and increasing degradation. This phenomenon is a key mechanism underlying the decreased insulin sensitivity seen in obesity and Type 2 diabetes mellitus. - Costanzo Physiology 7e, p. 447
5. Nuclear and Organelle Effects
Beyond the plasma membrane cascade, insulin also binds to elements in the nucleus, Golgi apparatus, and endoplasmic reticulum, where it directly stimulates gene transcription - an action similar to that of IGF-1 and IGF-2. - Costanzo Physiology 7e
Summary Table
| Level | Key Players | Effect |
|---|
| Receptor | α/β tetramer, tyrosine kinase | Binding + autophosphorylation |
| Docking proteins | IRS-1 to 4, Shc, Grb2 | Signal branching |
| Metabolic branch | PI3K → PDK1 → Akt | GLUT4, glycogen synthesis, anti-gluconeogenesis |
| Mitogenic branch | Ras → Raf → MEK → ERK | Cell growth, gene transcription |
| Termination | Receptor internalization, phosphatases (PTP1B) | Signal attenuation |
Clinical relevance: Defects at any step in this cascade (particularly at IRS-1/2, PI3K, or Akt levels) contribute to insulin resistance in Type 2 diabetes and metabolic syndrome. PTP1B (protein tyrosine phosphatase 1B) is a key phosphatase that terminates insulin signaling and is an active drug target for insulin-sensitizing therapies.